SAVARA INC's ticker is SVRA and the CUSIP is 805111101. A total of 80 filers reported holding SAVARA INC in Q4 2019. The put-call ratio across all filers is 0.83 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $102,658 | -49.2% | 52,645 | -65.9% | 0.00% | -60.0% |
| Q1 2022 | $202,000 | +5.8% | 154,263 | 0.0% | 0.01% | +25.0% |
| Q4 2021 | $191,000 | -10.3% | 154,263 | 0.0% | 0.00% | -33.3% |
| Q3 2021 | $213,000 | -42.4% | 154,263 | -29.1% | 0.01% | -50.0% |
| Q2 2021 | $370,000 | -11.7% | 217,560 | +8.1% | 0.01% | -25.0% |
| Q1 2021 | $419,000 | +46.5% | 201,309 | +75.1% | 0.02% | -20.0% |
| Q2 2020 | $286,000 | +286.5% | 115,000 | +311.7% | 0.02% | +185.7% |
| Q3 2019 | $74,000 | -32.7% | 27,931 | +132.8% | 0.01% | -46.2% |
| Q1 2018 | $110,000 | – | 12,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 4,980,804 | $16,026,005 | 46.25% |
| NEA Management Company, LLC | 24,137,931 | $77,120,690 | 5.89% |
| Bain Capital Life Sciences Investors, LLC | 11,622,598 | $37,134,201 | 3.82% |
| VR Adviser, LLC | 6,351,531 | $20,293,142 | 3.24% |
| Sio Capital Management, LLC | 1,010,701 | $3,229,190 | 0.82% |
| ACUTA CAPITAL PARTNERS, LLC | 198,139 | $633,054 | 0.43% |
| FARALLON CAPITAL MANAGEMENT LLC | 10,908,086 | $34,851,335 | 0.18% |
| Parkman Healthcare Partners LLC | 206,607 | $660,109 | 0.11% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 6,064,551 | $19,376,240 | 0.04% |
| ClariVest Asset Management LLC | 242,900 | $776 | 0.04% |